相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oocyte-somatic cell interactions in the human ovary-novel role of bone morphogenetic proteins and growth differentiation factors
Hsun-Ming Chang et al.
HUMAN REPRODUCTION UPDATE (2017)
The disparate origins of ovarian cancers: pathogenesis and prevention strategies
Anthony N. Karnezis et al.
NATURE REVIEWS CANCER (2017)
Role of dihydrotestosterone (DHT) on TGF-β1 signaling pathway in epithelial ovarian cancer cells
Karla Kohan-Ivani et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies
M. Petrillo et al.
ANNALS OF ONCOLOGY (2016)
The TGFβ pathway stimulates ovarian cancer cell proliferation by increasing IGF1R levels
Elisenda Alsina-Sanchis et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube
Mark A. Eckert et al.
CANCER DISCOVERY (2016)
Activins and activin antagonists in the human ovary and ovarian cancer
Karen L. Reader et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
FOXO1/3 and PTEN Depletion in Granulosa Cells Promotes Ovarian Granulosa Cell Tumor Development
Zhilin Liu et al.
MOLECULAR ENDOCRINOLOGY (2015)
Targeting the TGFβ pathway for cancer therapy
Cindy Neuzillet et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling
Ronald L. Chandler et al.
NATURE COMMUNICATIONS (2015)
Ubiquitin specific protease 22 promotes cell proliferation and tumor growth of epithelial ovarian cancer through synergy with transforming growth factor β1
Mei Ji et al.
ONCOLOGY REPORTS (2015)
TGF-β isoforms induce EMT independent migration of ovarian cancer cells
Jingfang Gao et al.
CANCER CELL INTERNATIONAL (2014)
microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition
Aditya Parikh et al.
NATURE COMMUNICATIONS (2014)
Active CREB1 Promotes a Malignant TGFβ2 Autocrine Loop in Glioblastoma
Laura Rodon et al.
CANCER DISCOVERY (2014)
Targeting IGF-1 signaling pathways in gynecologic malignancies
Ilan Bruchim et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Correction: Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II
Francesco Dituri et al.
PLoS One (2013)
Survival for Ovarian Cancer in Europe: The across-country variation did not shrink in the past decade
Willi Oberaigner et al.
ACTA ONCOLOGICA (2012)
USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor
Long Zhang et al.
NATURE CELL BIOLOGY (2012)
USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma
Pieter J. A. Eichhorn et al.
NATURE MEDICINE (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features
Jaime Prat
VIRCHOWS ARCHIV (2012)
USP11 augments TGFβ signalling by deubiquitylating ALK5
Mazin A. Al-Salihi et al.
OPEN BIOLOGY (2012)
Transforming growth factor-β and the hallmarks of cancer
Maozhen Tian et al.
CELLULAR SIGNALLING (2011)
TGF-β Blockade Controls Ascites by Preventing Abnormalization of Lymphatic Vessels in Orthotopic Human Ovarian Carcinoma Models
Shan Liao et al.
CLINICAL CANCER RESEARCH (2011)
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-Shifting the paradigm
Robert J. Kurman et al.
HUMAN PATHOLOGY (2011)
Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma
Elisabetta Kuhn et al.
MODERN PATHOLOGY (2011)
Expression of TGFβ1 and its receptors is associated with biological features of ovarian cancer and sensitivity to paclitaxel/carboplatin
Shinichi Komiyama et al.
ONCOLOGY REPORTS (2011)
Modeling high-grade serous ovarian carcinogenesis from the fallopian tube
Alison M. Karst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan et al.
NATURE REVIEWS CANCER (2011)
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Robert J. Kurman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Estimates of cancer incidence and mortality in Europe in 2008
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2010)
Integrated genomics of chemotherapy resistant ovarian cancer: A role for extracellular matrix, TGFbeta and regulating microRNAs
Jozien Helleman et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Changes in expression, and/or mutations in TGF-β receptors (TGF-β RI and TGF-β RII) and Smad 4 in human ovarian tumors
Marie Lue Antony et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
Redundant Roles of SMAD2 and SMAD3 in Ovarian Granulosa Cells In Vivo
Qinglei Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Transforming growth factor-β1, transforming growth factor-β2, and transforming growth factor-β3 enhance ovarian cancer metastatic potential by inducing a smad3-dependent epithelial-to-mesenchymal transition
Thuy-Vy Do et al.
MOLECULAR CANCER RESEARCH (2008)
The cell of origin of ovarian epithelial tumours
Louis Dubeau
LANCET ONCOLOGY (2008)
Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice
Stephanie A. Pangas et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study
Franco Berrino et al.
LANCET ONCOLOGY (2007)
High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene
Alejandra Bruna et al.
CANCER CELL (2007)
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Y. Lee et al.
JOURNAL OF PATHOLOGY (2007)
TGF-β superfamily members and ovarian follicle development
Phil G. Knight et al.
REPRODUCTION (2006)
The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome
F Medeiros et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
TGFBR1*6A and cancer risk:: A meta-analysis of seven case-control studies
VG Kaklamani et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Inhibition of the antiproliferative effect of TGFβ by EGF in primary human ovarian cancer cells
LD Dunfield et al.
ONCOGENE (2003)
Expression and action of transforming growth factor beta (TGFβ1, TGFβ2, TGFβ3) in normal bovine ovarian surface epithelium and implications for human ovarian cancer
E Nilsson et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2001)
分享论文
